logo

Search for

Search

Advanced Search

Code

Title

Researchers

Status

273-108-2559 (5) GAVI Health Systems Strengthening Support (HSS) Study

Completed:100%

27-3-108-2559 (6) Introduction of Pneumococcal Conjugate Vaccine (PCV) in Bhutan

Completed:100%

iDSI India

Completed:100%

GEAR

Completed:100%

10-5-004-2557 Policy Brief: Conducive Factors to HTA Development in Asia

Completed:100%

10-2-017-2558 (1) Technical assistance to perform an economic analysis to assess the cost-effectiveness of introducing seasonal influenza vaccines

Completed:100%

N/A Methods for Economic Evaluation Project (MEEP)

Completed:100%

FCTC Reflecting on a Decade of Achievement and Strengthening a Multi-sectoral Approach to Implementation

Scoping and protocol development:%

10-2-016-2558 Social Costs of Tobacco and Alcohol in Sri Lanka

Completed:100%

10-2-016-2558 Free Drugs List (FDL) Nepal

Completed:100%

10-2-016-2558 Package of Essential Non-communicable Disease Interventions Economic Evaluation (PEN EE)

Completed:100%

10-3-085-2557 Maternal Child and Health Voucher Scheme (MCHVS)

Completed:100%

10-2-011-2557 An Analysis Of Cost-Effectiveness Of Seasonal Influenza Vaccine Introduction In Nepal

Completed:100%

N/A Groundwork: Pre-Conditions for Successful Healthcare Priority Setting

Completed:100%

20-2-012-2557 iDSI Vietnam

Completed:100%

27-3-084-2557 iDSI Indonesia

Completed:100%

20-2-008-2556 IDSI Philippines

Completed:100%

26-1-011-2556 Assessing decision maker needs and the transferabilty of information across countries and regions

Completed:100%

63041011RM013L0 The development of recommendations for expanding health promotion and disease prevention benefit package under the universal health coverage Witthawat Pantumongkol

Conducting Research:38%

63171010RM017F0 An early health technology assessment of target product profiles for COVID-19 vaccines: data for supporting R&D for better vaccine and selecting the right vaccine for maximising public health impact Pattara Leelahavarong, PhD.

Conducting Research:36%